The insider selling cluster is too small relative to market cap to warrant a directional signal. Monitor for any upcoming earnings or pipeline catalysts that could explain the timing, but the sales are likely routine portfolio diversification or tax-related. No immediate trading action is indicated.
Price Chart
Executive Summary
Four insiders at Neurocrine Biosciences sold a total of $4.53M in stock over a one-week window, including the Chief Scientific Officer, Chief Human Resources Officer, Chief Regulatory Officer, and a Director. The sales represent approximately 0.028% of the company's $16.4B market cap, which is well below the 0.1% threshold for materiality. The cluster is dominated by C-suite executives, but the dollar amounts are trivial relative to market cap, and no open-market purchases or non-routine patterns are present.
Key Financial Metrics
Key Facts
- Four insiders sold a total of $4.53M in stock over 8 days (May 29 – June 5, 2026).
- Sales include the Chief Scientific Officer ($1.76M), Chief Human Resources Officer ($2.20M), Chief Regulatory Officer ($354K), and a Director ($210K).
- Total sales represent ~0.028% of Neurocrine's $16.4B market cap, far below the 0.1% materiality threshold.
- No open-market purchases were reported in the cluster.
- One non-cash gift of 2,441 shares by the Chief Scientific Officer was also filed but has no economic value.
Financial Impact
Total insider sales of $4.53M represent ~0.028% of market cap — immaterial.
Risk Factors
- Insider selling could accelerate if a negative catalyst emerges, but current levels are not predictive.
- No open-market buying to offset the selling — a lack of insider conviction on the buy side.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-NBIX-1781040973795 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 15, 2026 17d ago | Insider Cluster | $149.50 $139.49 | ▼ −6.70% | ▼ −9.26% | $143.18 (−4.23%) |
Jul 13, 2026 11w ago | Insider Cluster | $174.10 $170.88 | ▼ −1.85% | ▼ −1.06% | $143.18 (−17.76%) |
Jul 9, 2026 12w ago | Press Release | $177.11 $171.55 | ▼ −3.14% | ▼ −2.58% | $143.18 (−19.16%) |
Jun 9, 2026 16w ago | Insider Cluster | $160.86 $156.42 | ▼ −2.76% | ▼ −6.19% | $143.18 (−10.99%) |
Jun 8, 2026 16w ago | Insider Cluster | $165.24 $159.51 | ▼ −3.47% | ▼ −5.88% | $143.18 (−13.35%) |
Jun 8, 2026 16w ago | Insider Cluster | $165.24 $159.51 | ▼ −3.47% | ▼ −5.88% | $143.18 (−13.35%) |
Jun 4, 2026 17w ago | Insider Cluster | $163.88 $159.76 | ▼ −2.51% | ▼ −3.08% | $143.18 (−12.63%) |
Jun 2, 2026 17w ago | Insider Cluster | $164.23 $160.86 | ▼ −2.05% | ▲ +1.77% | $143.18 (−12.81%) |
Jun 2, 2026 17w ago | Insider Cluster | $164.23 $160.86 | ▼ −2.05% | ▲ +1.77% | $143.18 (−12.81%) |
Jun 2, 2026 17w ago | Insider Cluster | $164.23 $160.86 | ▼ −2.05% | ▲ +1.77% | $143.18 (−12.81%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access